LNC therapeutics leading biotech in the development of innovative microbiome-based therapies

LNC Therapeutics, a leading biotech in next-generation microbiome-based therapies that harness the power of keystone single-strain bacteria

more +
lnc
Our Story

Our team is committed to deliver therapeutic solutions to patients with high needs

more +
lnc
therapeutic solutions
lnc

LNC Therapeutics is the 1st company to harness the therapeutic potential of Christensenella

Our leadership

Georges RAWADI
Georges RAWADI CEO
Georges RAWADI
CEO

Passionate about innovation

A former researcher at the Institut Pasteur, Georges was Vice-President of Business Development & Intellectual Property and a member of the management team at Celyad.

Sandrine CLAUS
Sandrine CLAUS CSO
Sandrine CLAUS
CSO

Beyond the state of the art

Sandrine joined LNC Therapeutics in 2017 as Chief Scientific Officer and is also Associate Professor in Integrative Metabolism in the department of Food and Nutritional Sciences at the University of Reading.

Fabrice GUEZ
Fabrice GUEZ CFO
Fabrice GUEZ
CFO

Putting people first

An experienced CFO, Fabrice decided to switch gears after gaining extensive experience as a financial auditor, getting involved in operations at a number of pharmaceutical SMEs, where he successfully headed up change management processes.

Leveraging partnership for success more +
ICAN
LuinaBio
INRA
Quay Pharma
Cornel University
Bioaster
lnc
Where
to meet us
4-6 February, 2020
Microbiome Drug Development Summit - Europe -
> more
10-11 March, 2020
Pharmabiotics 2020
> more
23-25 March, 2020
BioSpring Europe 2020
> more
11-12 May, 2020
BioEquity Europe 2020
> more
8-11 June, 2020
Bio International Convention 2020
> more
28-30 June, 2020
IHMC Congress 2020
> more
Microbiome & us
News
Mar 12, 2020
LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial | By finalizing the...
> more
Jan 13, 2020
We are looking for Clinical Project Manager | WHAT WE OFFER An exciting opportunity to dive in and begin your career...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Publications
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
Oct 28, 2019
Jillian L. Waters, Ruth E. Ley The Christensenellaceae, a recently described family in the phylum Firmicutes, is emerging...
> more
now on twitter
LNC Therapeutics

What is the potential impact to #biotechnology and human health? And what about the role of the #microbiome?… t.co/YOdPzyuzpF

LNC Therapeutics © 2020 - all rights reserved terms and conditions Influa | Web Agency © 2018